BLFS
Price
$24.50
Change
+$0.32 (+1.32%)
Updated
Sep 26, 01:28 PM (EDT)
Capitalization
1.16B
41 days until earnings call
VTAK
Price
$2.25
Change
-$0.01 (-0.44%)
Updated
Sep 26, 01:20 PM (EDT)
Capitalization
3.36M
Interact to see
Advertisement

BLFS vs VTAK

Header iconBLFS vs VTAK Comparison
Open Charts BLFS vs VTAKBanner chart's image
BioLife Solutions
Price$24.50
Change+$0.32 (+1.32%)
Volume$301
Capitalization1.16B
Catheter Precision
Price$2.25
Change-$0.01 (-0.44%)
Volume$180
Capitalization3.36M
BLFS vs VTAK Comparison Chart in %
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. VTAK commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Buy and VTAK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (BLFS: $24.18 vs. VTAK: $2.26)
Brand notoriety: BLFS and VTAK are both not notable
BLFS represents the Pharmaceuticals: Other, while VTAK is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BLFS: 63% vs. VTAK: 4%
Market capitalization -- BLFS: $1.16B vs. VTAK: $3.36M
BLFS [@Pharmaceuticals: Other] is valued at $1.16B. VTAK’s [@Medical/Nursing Services] market capitalization is $3.36M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileVTAK’s FA Score has 2 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • VTAK’s FA Score: 2 green, 3 red.
According to our system of comparison, VTAK is a better buy in the long-term than BLFS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 4 TA indicator(s) are bullish while VTAK’s TA Score has 2 bullish TA indicator(s).

  • BLFS’s TA Score: 4 bullish, 4 bearish.
  • VTAK’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than VTAK.

Price Growth

BLFS (@Pharmaceuticals: Other) experienced а -7.99% price change this week, while VTAK (@Medical/Nursing Services) price change was -15.99% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.30%. For the same industry, the average monthly price growth was -3.34%, and the average quarterly price growth was +8.48%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.74%. For the same industry, the average monthly price growth was +3.22%, and the average quarterly price growth was +9.80%.

Reported Earning Dates

BLFS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.74% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($1.16B) has a higher market cap than VTAK($3.36M). BLFS YTD gains are higher at: -6.857 vs. VTAK (-73.626). BLFS has higher annual earnings (EBITDA): 17.4M vs. VTAK (-15.46M). BLFS has more cash in the bank: 81.8M vs. VTAK (1.71M). VTAK has less debt than BLFS: VTAK (3.66M) vs BLFS (23.8M). BLFS has higher revenues than VTAK: BLFS (93.5M) vs VTAK (600K).
BLFSVTAKBLFS / VTAK
Capitalization1.16B3.36M34,454%
EBITDA17.4M-15.46M-113%
Gain YTD-6.857-73.6269%
P/E RatioN/A0.07-
Revenue93.5M600K15,583%
Total Cash81.8M1.71M4,778%
Total Debt23.8M3.66M650%
FUNDAMENTALS RATINGS
BLFS vs VTAK: Fundamental Ratings
BLFS
VTAK
OUTLOOK RATING
1..100
688
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
27
Undervalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
5996
P/E GROWTH RATING
1..100
133
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTAK's Valuation (27) in the Medical Specialties industry is significantly better than the same rating for BLFS (99). This means that VTAK’s stock grew significantly faster than BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (93) in the Medical Specialties industry is in the same range as VTAK (100). This means that BLFS’s stock grew similarly to VTAK’s over the last 12 months.

BLFS's SMR Rating (92) in the Medical Specialties industry is in the same range as VTAK (100). This means that BLFS’s stock grew similarly to VTAK’s over the last 12 months.

BLFS's Price Growth Rating (59) in the Medical Specialties industry is somewhat better than the same rating for VTAK (96). This means that BLFS’s stock grew somewhat faster than VTAK’s over the last 12 months.

VTAK's P/E Growth Rating (3) in the Medical Specialties industry is in the same range as BLFS (13). This means that VTAK’s stock grew similarly to BLFS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSVTAK
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USNQX60.44N/A
N/A
Victory NASDAQ-100 Index
USEMX25.84N/A
N/A
Victory Emerging Markets
TLGYX67.50N/A
N/A
Touchstone Large Company Growth Y
CLVRX35.73N/A
N/A
Calvert US Large Cap Value Rspnb Idx R6
WCMAX11.52N/A
N/A
WCM Mid Cap Quality Value Institutional

VTAK and

Correlation & Price change

A.I.dvisor tells us that VTAK and PRPO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VTAK and PRPO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTAK
1D Price
Change %
VTAK100%
-5.04%
PRPO - VTAK
27%
Poorly correlated
+1.68%
BLFS - VTAK
25%
Poorly correlated
+0.29%
SGHT - VTAK
25%
Poorly correlated
-3.11%
CSTL - VTAK
25%
Poorly correlated
+0.31%
CERS - VTAK
25%
Poorly correlated
-1.95%
More